- Home
- FSP vs ECOR Comparison
FSP vs ECOR Comparison
Compare FSP & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSP | ECOR |
|---|---|---|
| Founded | 1981 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4M | 81.0M |
| IPO Year | 2001 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FSP | ECOR |
|---|---|---|
| Price | $0.63 | $9.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 552.7K | 174.9K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.34% | N/A |
| EPS Growth | ★ 15.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $107,162,000.00 | $32,032,000.00 |
| Revenue This Year | $17.91 | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $0.50 | $4.16 |
| 52 Week High | $1.82 | $10.45 |
Technical Indicators
Market Signals| Indicator | FSP | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 57.23 |
| Support Level | $0.58 | $4.92 |
| Resistance Level | $0.70 | $10.37 |
| Average True Range (ATR) | 0.06 | 1.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 51.01 | 44.47 |
Price Performance
Historical ComparisonAbout FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.